This review synthesizes recent findings on IL-31 and IL-33 in AD, identifies gaps and conflicting data in current knowledge, and proposes research directions to elucidate the mechanistic interplay between these cytokines in AD pathogenesis and inflammation. The gene discussed is IL33; the disease is Alzheimer disease.